Пациентите, лекувани с Pramipexole Teva при които се наблюдава сънливост и/ или внезапно заспиване през деня, трябва да бъдат предупредени да не шофират и да не
Patients being treated with Pramipexole Teva and presenting with somnolence and/ or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e. g. operating machines) until such recurrent episodes and somnolence have resolved (see also sections 4.4, 4.5, and 4.8).